A blog bringing you perspectives from the frontlines of the drug pricing debate.

New Study Shows Big Pharma’s Prices Push Drug Costs Higher

Anyone following the U.S. drug pricing debate knows that “drug prices” are complicated. Most brand-name prescription drugs sold…

Georgia Legislators Should Preserve Tools to Lower Drug Prices

Published in The Newnan Times-Herald As COVID-19 continues to impact the nation, Georgia’s Governor and state legislature are…

PBMs Providing Patient Access to Medicine During COVID-19

Today, millions of Americans are staying home during the threat of COVID-19. Access to affordable prescription drugs remains…

Health Care Purchasers Call on Congress to Take Action to Boost Competition

By Debra Barrett, Coalition for Affordable Prescription Drugs, James Gelfand, ERIC and Andrew MacPherson, Public Sector HealthCare Roundtable…

Pharmacy Benefit Managers Are Key to Helping Retirees

Published in Morning Consult  With the United States in a debate on high drug prices, solutions are being…

Tapping into the Generic Pipeline in 2020: Savings for Consumers

Three months into 2020 and the prescription drug pricing crisis continues to grow; in January alone, drug manufacturers…

Creating a Competitive Marketplace that Works for Patients

U.S. patients, payors and the health care system are spending billions of dollars more on prescription drugs than…

Drug Pricing: Questions for the Presidential Candidates

With the Iowa caucuses and New Hampshire primary taking the spotlight, national attention on the presidential race and…

Meaningful Transparency

As policymakers seek to address widespread concern about high drug prices, the conversation often includes a call for…

Creating a Marketplace that Works for Patients

The challenge of high and rising drug prices affects almost all Americans – and voters are unified in…